145 related articles for article (PubMed ID: 26676084)
21. The role of ACPAs in at-risk individuals: Early targeting of the bone and joints.
Schett G
Best Pract Res Clin Rheumatol; 2017 Feb; 31(1):53-58. PubMed ID: 29221598
[TBL] [Abstract][Full Text] [Related]
22. [The pathogenic role of ACPA in rheumatoid arthritis].
Umeda N; Matsumoto I; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):391-395. PubMed ID: 29367523
[TBL] [Abstract][Full Text] [Related]
23. Bone and cytokines: beyond IL-1, IL-6 and TNF-alpha.
Rifas L
Calcif Tissue Int; 1999 Jan; 64(1):1-7. PubMed ID: 9868276
[No Abstract] [Full Text] [Related]
24. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.
Barra L; Scinocca M; Saunders S; Bhayana R; Rohekar S; Racapé M; Coles R; Cairns E; Bell DA
Arthritis Rheum; 2013 Jun; 65(6):1439-47. PubMed ID: 23450693
[TBL] [Abstract][Full Text] [Related]
25. Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications.
Shim JH; Stavre Z; Gravallese EM
Calcif Tissue Int; 2018 May; 102(5):533-546. PubMed ID: 29204672
[TBL] [Abstract][Full Text] [Related]
26. [Fibroblastic modulators of bone destruction].
Dankbar B; Pap T
Z Rheumatol; 2016 Aug; 75(6):534-6. PubMed ID: 27418056
[No Abstract] [Full Text] [Related]
27. Comment on "Regulatory T cells protect from local and systemic bone destruction in arthritis".
Yuan FL; Lu WG; Li X; Li JP; Li CW; Xu RS
J Immunol; 2011 Jan; 186(1):3; author reply 3-4. PubMed ID: 21172870
[No Abstract] [Full Text] [Related]
28. The dynamic interplay between osteoclasts and the immune system.
Nakashima T; Takayanagi H
Arch Biochem Biophys; 2008 May; 473(2):166-71. PubMed ID: 18410741
[TBL] [Abstract][Full Text] [Related]
29. B cell autoimmunity and bone damage in rheumatoid arthritis.
Bugatti S; Bogliolo L; Montecucco C; Manzo A
Reumatismo; 2016 Dec; 68(3):117-125. PubMed ID: 27981813
[TBL] [Abstract][Full Text] [Related]
30. [Inflammatory cytokines in rheumatoid arthritis].
Murakami M; Nishimoto N
Clin Calcium; 2012 Nov; 22(11):1737-46. PubMed ID: 23103817
[TBL] [Abstract][Full Text] [Related]
31. Gauging rheumatoid arthritis.
van Schaardenburg D
Neth J Med; 2012 Nov; 70(9):389-91. PubMed ID: 23123532
[No Abstract] [Full Text] [Related]
32. Unlocking the "PAD" lock on rheumatoid arthritis.
Utz PJ; Genovese MC; Robinson WH
Ann Rheum Dis; 2004 Apr; 63(4):330-2. PubMed ID: 15020322
[No Abstract] [Full Text] [Related]
33. Fingerprinting of anti-citrullinated protein antibodies (ACPA): specificity, isotypes and subclasses.
Pratesi F; Panza F; Paolini I; Petrelli F; Puxeddu I; Casigliani-Rabl S; Ancillotti D; Alcaro C; Rovero P; Migliorini P
Lupus; 2015 Apr; 24(4-5):433-41. PubMed ID: 25801886
[TBL] [Abstract][Full Text] [Related]
34. S100A8 enhances osteoclastic bone resorption in vitro through activation of Toll-like receptor 4: implications for bone destruction in murine antigen-induced arthritis.
Grevers LC; de Vries TJ; Vogl T; Abdollahi-Roodsaz S; Sloetjes AW; Leenen PJ; Roth J; Everts V; van den Berg WB; van Lent PL
Arthritis Rheum; 2011 May; 63(5):1365-75. PubMed ID: 21337316
[TBL] [Abstract][Full Text] [Related]
35. Citrullinated proteins in rheumatoid arthritis: crucial...but not sufficient!
Cantaert T; De Rycke L; Bongartz T; Matteson EL; Tak PP; Nicholas AP; Baeten D
Arthritis Rheum; 2006 Nov; 54(11):3381-9. PubMed ID: 17075816
[No Abstract] [Full Text] [Related]
36. Affinity Purification and Comparative Biosensor Analysis of Citrulline-Peptide-Specific Antibodies in Rheumatoid Arthritis.
Szarka E; Aradi P; Huber K; Pozsgay J; Végh L; Magyar A; Gyulai G; Nagy G; Rojkovich B; Kiss É; Hudecz F; Sármay G
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361749
[TBL] [Abstract][Full Text] [Related]
37. Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.
Baum R; Gravallese EM
Clin Rev Allergy Immunol; 2016 Aug; 51(1):1-15. PubMed ID: 26411424
[TBL] [Abstract][Full Text] [Related]
38. Myeloid-derived suppressor cells contribute to bone erosion in collagen-induced arthritis by differentiating to osteoclasts.
Zhang H; Huang Y; Wang S; Fu R; Guo C; Wang H; Zhao J; Gaskin F; Chen J; Yang N; Fu SM
J Autoimmun; 2015 Dec; 65():82-9. PubMed ID: 26318644
[TBL] [Abstract][Full Text] [Related]
39. Cellular and molecular pathways of structural damage in rheumatoid arthritis.
Harre U; Schett G
Semin Immunopathol; 2017 Jun; 39(4):355-363. PubMed ID: 28597065
[TBL] [Abstract][Full Text] [Related]
40. Absence of citrulline-specific autoantibodies in animal models of autoimmunity.
Vossenaar ER; van Boekel MA; van Venrooij WJ; López-Hoyoz M; Merino J; Merino R; Joosten LA
Arthritis Rheum; 2004 Jul; 50(7):2370-2. PubMed ID: 15248238
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
